Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2023-06-30
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study of FRC Implant to Treat Skull Bone Defects
NCT01874613
Cranioplasty: Autogenous Bone Graft Versus Artificial Substitutes
NCT03218150
Cranioplasty Using Titanium Mesh Vs Bone Cement
NCT06662903
Guided Bone Regeneration With and Without the Use of Intra-marrow Penetrations
NCT06353399
OSsIRIS Study - A Post-market Clinical Follow-up Investigation.
NCT06156904
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CUSABT
Subject receives use of the CUSA Clarity Bone Tip product during cranial skull base bone removal surgery
CUSABT
Subject receives use of the CUSA Clarity Bone Tip product during cranial skull base bone removal surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CUSABT
Subject receives use of the CUSA Clarity Bone Tip product during cranial skull base bone removal surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject requires a cranial skull base procedure involving removal of bone with ultrasonic aspirator
* Subject is an appropriate candidate to receive use of the CUSA Clarity Bone Tip product during cranial skull base bone removal surgery, per the study surgeon
* Subject signed the IRB/EC-approved informed consent form demonstrating that the subject is willing and able to participate in this clinical study and to comply with all study procedures
Exclusion Criteria
* Subject has any significant medical condition that in the opinion of the investigator will interfere with protocol evaluation and participation
* Subject's surgical plan includes utilizing CUSA Clarity Bone Tip for bone removal anywhere besides the cranial skull base in an open craniotomy (e.g. transsphenoidal approach or spinal procedures).
* Subject is a prisoner or member of a different vulnerable population that should not be included in the study per the investigator or ethics committee.
* Surgeon does not utilize CUSA Clarity Bone Tip for cranial skull base bone removal during surgery or utilizes CUSA Clarity Bone Tip anywhere else besides the cranial skull base
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Integra LifeSciences Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jason Marzuola
Role: STUDY_DIRECTOR
Integra LifeSciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Barbara-Klinik Hamm-Heessen Klinik für Neurochirurgie
Hamm, , Germany
Universitätsklinikum Münster Klinik und Poliklinik für Neurochirurgie
Münster, , Germany
General Hospital of Athens "Georgios Gennimatas"
Athens, , Greece
Azienda Ospedaliero-Universitaria Consorziale Policlinico
Bari, , Italy
Ospedale di Treviso
Treviso, , Italy
Azienda Sanitaria Universitaria Integrata di Udine
Udine, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-CUSABT-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.